NCT03176485
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +48 more
- Locations
-
- University of Arizona Cancer Center Tucson, Arizona, United States
Clinical trial condition
HCC
Explore clinical trials studying HCC. Study availability and eligibility vary by location and protocol.
97 public trials
30 recruiting studies
HCC trial results
NCT02833298
- Conditions
- Adenocarcinoma, Blood-Borne Infections, Carcinoma, +20 more
- Locations
-
- Icahn School of Medicine at Mount Sinai New York, United States
NCT02971696
- Conditions
- HCC
- Locations
-
- El Kahraba Hosital Cairo, N/A = Not Applicable, Egypt
- Ain Shams University Hospital Cairo, Egypt
- Nasser Institute Cairo, Egypt
Completed
Modeling Cancer-specific Prognosis in Liver Transplantation for Hepatocellular Carcinoma (HCC)
NCT02898415
- Conditions
- Alphafetoprotein, Cancer Recurrence, Competing Risk, +8 more
- Locations
-
Not specified
Completed
ISP-TACE Versus TACE for HCC With PVTT
NCT03108248
- Conditions
- HCC, Portal Vein Tumor Thrombosis
- Locations
-
- Zhongda Hospital,Southeast University Nanjing, Jiangsu, China
NCT03045419
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
Completed
Safety Margin Assessment After RFA Using the Registration of Pre-ablation MRI and Post-ablation CT
NCT02985034
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
Active, Not Recruiting
Optimizing Y90 Therapy for Radiation Lobectomy
NCT04390724
- Conditions
- Adenocarcinoma, Adult Primary Liver Cancer, Carcinoma, +17 more
- Locations
-
- Mayo Clinic Jacksonville, Florida, United States
- Northwestern University Chicago, Illinois, United States
Active, Not Recruiting
Durvalumab and Tremelimumab in Combination With Y-90 SIRT for Intermediate Stage HCC
NCT04522544
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Universitätsklinikum Bonn Bonn, Germany
- Universitätsklinikum Köln Cologne, Germany
- Universitätsklinikum Essen Essen, Germany
- Universitätsmedizin Göttingen Göttingen, Germany
Active, Not Recruiting
CXD101 in Immunotherapy-related Liver Cancer
NCT05873244
- Conditions
- HCC
- Locations
-
- Department of Clinical Oncology, Prince of Wales Hospital Hong Kong
- School of Biomedical Science, The Chinese University of Hong Kong Hong Kong